DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ advanced 4.73% to $654.27 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,483.24 and the Dow Jones Industrial Average rising 1.14% to 52,900.07.
This was the stock's second consecutive day of gains.
Regeneron Pharmaceuticals Inc. closed 20.32% below its 52-week high of $821.11, which the company achieved on January 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Amgen Inc. $(AMGN)$ rose 3.55% to $374.15, Moderna Inc. (MRNA) rose 10.01% to $79.76, and Gilead Sciences Inc. (GILD) rose 4.21% to $131.27.
Trading volume (1.0 M) remained 38,681 below its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 2, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 02, 2026 16:44 ET (20:44 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments